- To examine the evolution of Children's Health Insurance Program (CHIP) and Medicaid programs after passage of the Children's Health Insurance Program Reauthorization Act of 2009 (CHIPRA), focusing on policies affecting eligibility, enrollment, renewal, benefits, access to care, cost sharing, and preparation for health care reform.
- The Children's Health Insurance Program (CHIP) Reauthorization Act (CHIPRA) reauthorized CHIP through federal fiscal year 2019 and, together with provisions in the Affordable Care Act, federal funding for the program was extended through federal fiscal year 2015. Congressional action is required or federal funding for the program will end in September 2015. This supplement to Academic Pediatrics is intended to inform discussions about CHIP's future. Most of the new research presented comes from a large evaluation of CHIP mandated by Congress in the CHIPRA.
- We sought to explore the claims data-related issues relevant to quality measure development for Medicaid and the Children's Health Insurance Program (CHIP), illustrating the challenges encountered and solutions developed around 3 distinct performance measure topics: care coordination for children with complex needs, quality of care for high-prevalence conditions, and hospital readmissions.
- To describe the process used to identify the recommended core set of quality measures as mandated by the Children’s Health Insurance Program Reauthorization Act of 2009 (CHIPRA) and provide an overview of the measures selected.
- The objective of this research was to explore state Medicaid and Children’s Health Insurance Program (CHIP) use of children’s healthcare quality measures and the need for additional support as the Children’s Health Insurance Program Reauthorization Act (CHIPRA) legislation is being implemented.
- The aim of this review was to evaluate the impact of managed care on publicly insured children with special health care needs (CSHCN).